Form 4: Columbia Financial, Inc.: Executive Vice President & Chief Risk Officer John Klimowich Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John Klimowich, EVP & Chief Risk Officer of Columbia Financial, Inc., reports changes in beneficial ownership of company stock, including acquisitions via a stock-based deferral plan and holdings through various employee benefit plans.
Summary
- On March 15, 2024, John Klimowich, the EVP & Chief Risk Officer of Columbia Financial, Inc., reported changes in his beneficial ownership of the company's stock.
- He acquired 258.6315 shares of common stock at a price of $15.93 through the Columbia Bank Stock Based Deferral Plan.
- Following the reported transaction, Klimowich directly owns 53,205 shares of common stock and indirectly owns shares through various plans including a Stock-Based Deferral Plan (5,840.5658 shares), 401(k) (17,130 shares), ESOP (6,451 shares), SERP (6,602 shares), SIM (4,214 shares), Stock Award (7,693 shares), Stock Award II (16,537 shares), and Stock Award III (13,165 shares).
- Klimowich also holds options to buy 188,235 shares at $15.60 (vesting from July 23, 2020), 12,030 shares at $15.94 (vesting from May 1, 2024), and 8,850 shares at $16.49 (vesting from March 6, 2025).
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It reflects standard insider trading activity.
Positives
- The acquisition of shares through the Stock Based Deferral Plan indicates Klimowich's continued investment in the company's future.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their investment activities in the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the holdings and transactions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Stock Options (right to buy) $ 15.6 vest in five equal annual installments commencing on this date |
| 05/01/2024 | Stock Options (right to buy) $ 15.94 vest in three approximately equal annual installments commencing on this date |
| 03/06/2025 | Stock Options (right to buy) $ 16.49 vest in three approximately equal annual installments commencing on this date |
| 03/15/2024 | Date of transaction: Acquisition of common stock through Stock Based Deferral Plan. |
| 03/20/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.